Frank E Harrell Jr
Overview
Explore the profile of Frank E Harrell Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
142
Citations
7653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Uncertainty of risk estimates from clinical prediction models: rationale, challenges, and approaches
Riley R, Collins G, Kirton L, Snell K, Ensor J, Whittle R, et al.
BMJ
. 2025 Feb;
388:e080749.
PMID: 39947680
No abstract available.
2.
Butler J, Usman M, Harrell Jr F, Packer M
J Am Coll Cardiol
. 2025 Jan;
85(2):190-195.
PMID: 39814478
Patient-reported health status is an important assessment of patients with heart failure, but current approaches have substantial methodological and analytical limitations. Changes in the Kansas City Cardiomyopathy Questionnaire (KCCQ) are...
3.
Heuts S, Kawczynski M, Sayed A, Urbut S, Albuquerque A, Mandrola J, et al.
Can J Cardiol
. 2024 Nov;
41(1):30-44.
PMID: 39521054
The Bayesian analytical framework is clinically intuitive, characterised by the incorporation of previous evidence into the analysis and allowing an estimation of treatment effects and their associated uncertainties. The application...
4.
Mixon A, Goggins K, Nwosu S, Shi Y, Schildcrout J, Wallston K, et al.
Health Lit Res Pract
. 2024 Nov;
8(4):e212-e223.
PMID: 39510532
Background: The relative contributions of common patient-reported social determinants of health on 30- and 90-day post-discharge outcomes among patients with acute coronary syndromes (ACS) is unclear. Objective: The aim of...
5.
Foley M, Rajkumar C, Ahmed-Jushuf F, Simader F, Chotai S, Seligman H, et al.
Circulation
. 2024 Oct;
151(3):202-214.
PMID: 39462291
Background: ORBITA-2 (the Placebo-Controlled Trial of Percutaneous Coronary Intervention for the Relief of Stable Angina) provided evidence for the role of percutaneous coronary intervention (PCI) for angina relief in stable...
6.
Bloodworth M, Staso P, Huang S, Farber-Eger E, Niswender K, Harrell Jr F, et al.
Ann Allergy Asthma Immunol
. 2024 Sep;
133(6):660-666.e5.
PMID: 39293715
Background: Obesity and metabolic dysregulation (MetD) have increasing prevalence and adversely affect asthma morbidity and therapeutic response. Objective: To determine the role of weight and MetD on incident asthma in...
7.
Rohde M, French B, Stewart T, Harrell Jr F
Stat Med
. 2024 Jun;
43(18):3539-3561.
PMID: 38853380
Ordinal longitudinal outcomes are becoming common in clinical research, particularly in the context of COVID-19 clinical trials. These outcomes are information-rich and can increase the statistical efficiency of a study...
8.
9.
Simader F, Rajkumar C, Foley M, Ahmed-Jushuf F, Chotai S, Bual N, et al.
J Am Coll Cardiol
. 2024 May;
84(1):13-24.
PMID: 38759906
Background: Placebo-controlled evidence from ORBITA-2 (Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina-2) found that percutaneous coronary intervention (PCI) in stable coronary artery disease with...
10.
Rajkumar C, Foley M, Ahmed-Jushuf F, Simader F, Mohsin M, Ganesananthan S, et al.
J Am Coll Cardiol
. 2024 May;
84(1):1-12.
PMID: 38752902
Background: In stable coronary artery disease, 30% to 60% of patients remain symptomatic despite successful revascularization. Perhaps not all symptoms reported by a patient with myocardial ischemia are, in fact,...